Title : Budesonide/formoterol for maintenance and reliever therapy in the management of moderate to severe asthma.

Pub. Date : 2008 Dec

PMID : 19032229






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 For patients with moderate to severe asthma an inhaled corticosteroid (ICS) or an ICS/long-acting beta2-agonist (LABA) combination with a short-acting beta2-agonist (SABA) as reliever is recommended. 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole potassium calcium-activated channel subfamily M regulatory beta subunit 2 Homo sapiens